Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort.
Document Type
Article
Publication Date
9-26-2020
Publication Title
TH Open
Abstract
A hypercoagulable state has been described in coronavirus disease 2019 (COVID-19) patients. Others have reported a survival advantage with prophylactic anticoagulation (pAC) and therapeutic anticoagulation (tAC), but these retrospective analyses have important limitations such as confounding by indication. We studied the impact of tAC and pAC compared with no anticoagulation (AC) on time to death in COVID-19. We performed a cross-sectional analysis of 127 deceased COVID-19 patients and compared time to death in those who received tAC (
Volume
4
Issue
3
First Page
263
Last Page
270
Recommended Citation
Ionescu F, Grasso-Knight G, Castillo E, Naeem E, Petrescu I, Imam Z, Patel VK, Narasimhan M, Nair GB. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH Open. 2020 Sep 26;4(3):e263-e270. doi: 10.1055/s-0040-1716721. PMID: 32995704; PMCID: PMC7519875.
DOI
10.1055/s-0040-1716721
ISSN
2512-9465
PubMed ID
32995704